Injection filter needle market to reach $1.73 billion in 2025
Rising demands and advancements in eye care drive growth
Rising demands and advancements in eye care drive growth
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Yesafili, received marketing authorization approval from the European Commission for the European Union
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Subscribe To Our Newsletter & Stay Updated